Nasal Spray Version of Naloxone Approved to Treat Opioid Overdoses

The Food and Drug Administration (FDA) on Wednesday approved a nasal spray version of the opioid overdose antidote naloxone (Narcan). Until now, the only approved version of naloxone was injectable, The New York Times reports.

The company that makes the spray, Adapt Pharma, said it will offer the spray at a discount to emergency workers, police and firefighters.

Naloxone is used to reverse overdoses of opioids including prescription medications such as oxycodone, hydrocodone and morphine, as well as heroin. The FDA noted in a press release that if naloxone is administered quickly, it can counter the effects of an opioid overdose, usually within two minutes.

Full story of nasal spray version of Naloxone at drugfree.org

Published by

Will Savage

Quantum Units Continuing Education provides online CEU training's to licensed professional mental health therapists, counselors, social workers and nurses. Our blog provides updates in the field of news and research related to mental health and substance abuse treatment.